NCT07134569 Motor Function Assessment and VR-based Motor Training in Adults With Autism Spectrum Disorder
| NCT ID | NCT07134569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Autism |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-12-15 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2023-12-15 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if autism affect motor functions, including muscle strength, balance, and motor control? Additionally, understanding the motor functions, cognitive functions, and brain activation in individuals with autism, and verifying whether motor training can effectively improve muscle strength, balance, and motor control. The main questions aim to answer are: \[primary hypothesis or outcome measure 1\]? \[primary hypothesis or outcome measure 2\]? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].
Eligibility Criteria
\> The ASD Group Inclusion criteria: * young adult aged between 18 and 45 years who had a diagnosis of ASD from a licensed mental health or medical professional based on DSM-5. * was motivated to complete the 6-week VR-based motor function training. * had a full-scale IQ \> 70 on the WAIS-IV. Exclusion criteria: * a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury) that hamper walking function, or neurosurgery. * visual impairment and/or hearing impairment that would preclude participation in motor assessment or training. * The Non-ASD control group Inclusion criteria: * young adult aged between 18 and 45 years who do not have a diagnosis of ASD. * had a full-scale IQ \> 70 on the WAIS-IV. Exclusion criteria: * a history of major mental illness (e.g., bipolar affective disorder, schizophrenia, or psychosis), neurological diseases (e.g., stroke, lumbar radiculopathy, or spinal cord injury), or neurosurgery that hamper walking function. * visual impairment and/or hearing impairment that would preclude participation in motor assessment or training.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07134569 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Autism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07134569 currently recruiting?
Yes, NCT07134569 is actively recruiting participants. Contact the research team at ntuh.peers@gmail.com for enrollment information.
Where is the NCT07134569 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07134569 clinical trial?
NCT07134569 is sponsored by National Taiwan University Hospital. The trial plans to enroll 200 participants.